Giannini, M., Ellezam, B., Leclair, V., Lefebvre, F., Troyanov, Y., Hudson, M., . . . Meyer, A. (2023). Scleromyositis: A distinct novel entity within the systemic sclerosis and autoimmune myositis spectrum. Implications for care and pathogenesis. Frontiers in immunology, 13, 974078. https://doi.org/10.3389/fimmu.2022.974078
Citace podle Chicago (17th ed.)Giannini, Margherita, et al. "Scleromyositis: A Distinct Novel Entity Within the Systemic Sclerosis and Autoimmune Myositis Spectrum. Implications for Care and Pathogenesis." Frontiers in Immunology 13 (2023): 974078. https://doi.org/10.3389/fimmu.2022.974078.
Citace podle MLA (9th ed.)Giannini, Margherita, et al. "Scleromyositis: A Distinct Novel Entity Within the Systemic Sclerosis and Autoimmune Myositis Spectrum. Implications for Care and Pathogenesis." Frontiers in Immunology, vol. 13, 2023, p. 974078, https://doi.org/10.3389/fimmu.2022.974078.